# Advisor Review - Advisor 3/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-28T15:35:24.941152
**Response ID:** resp_0da5bcb9c9c5a15100697a1e2917548193b7874f942d348e3e
**Tokens:** 6241 in / 5873 out
**Response SHA256:** ce8db3b60473982f

---

## 1) DATA–DESIGN ALIGNMENT (CRITICAL)

- **Treatment timing vs data coverage:** Consistent. The outcome panel is **2011–2019** and the staggered-adoption cohorts used for identification are **2012–2019**. No treatment year exceeds the last data year.
- **Post-treatment observations:** Each treated cohort has at least some post-treatment support within 2011–2019 (even the 2019 cohort has a post period in 2019).
- **Treatment definition consistency:** Counts line up mechanically across the paper:
  - Table 1: 10 always-treated + 27 treated during 2012–2019 + 14 never-treated = **51 jurisdictions**
  - Table 3 and text: treated cohorts contributing to identification = **27** and cohorts (years) = **8** (2012–2019)
  - Table 4 cohort state counts sum to **27**

No fatal data-design misalignment found.

## 2) REGRESSION SANITY (CRITICAL)

Checked Tables 3–5 (and cohort ATTs in Table 4):
- Coefficient magnitudes are plausible given the outcome is a percentage-point prevalence.
- Standard errors are not explosively large and are not orders of magnitude larger than coefficients.
- Confidence intervals and p-values are arithmetically consistent with the reported estimates/SEs (e.g., Table 3 main ATT −0.48 with SE 0.35 implies a 95% CI about [−1.17, 0.21], matching the reported [−1.16, 0.20] up to rounding).
- No impossible values (NaN/Inf/negative SE/R² issues) appear.

No fatal regression-output sanity violations found.

## 3) COMPLETENESS (CRITICAL)

- Regression tables report **N** and **SEs/CIs** (Tables 3 and 5 explicitly; Table 4 reports ATT and SE).
- No placeholders (“TBD”, “NA”, “XXX”) visible in the provided draft.
- All referenced tables/figure in the provided excerpt exist (Table 1–5, Figure 1).

No fatal completeness problems found.

## 4) INTERNAL CONSISTENCY (CRITICAL)

- Key headline estimate is consistent across Abstract / Table 3 / Conclusion (ATT = −0.48, SE = 0.35).
- Sample period is consistent throughout (2011–2019).
- Jurisdiction counts are consistent (51 total; 37 ever-treated by 2019; 14 never-treated; 10 always-treated; 27 identifying-treated).

No fatal internal consistency errors found.

ADVISOR VERDICT: PASS